Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on SalesTimes Interest Earned

MDxHealth (MDXH) Invested Capital (2020 - 2026)

MDxHealth has reported Invested Capital over the past 7 years, most recently at $95.9 million for Q1 2026.

  • For Q1 2026, Invested Capital changed N/A year-over-year to $95.9 million; the TTM value through Dec 2025 reached $141.2 million, down 6.33%, while the annual FY2025 figure was $141.2 million, 6.33% down from the prior year.
  • Invested Capital was $95.9 million for Q1 2026 at MDxHealth, down from $141.2 million in the prior quarter.
  • Across five years, Invested Capital topped out at $150.8 million in Q4 2024 and bottomed at $44.2 million in Q4 2022.
  • The 5-year median for Invested Capital is $123.4 million (2023), against an average of $111.1 million.
  • Year-over-year, Invested Capital tumbled 38.86% in 2022 and then soared 179.09% in 2023.
  • Over 5 years, Invested Capital stood at $44.2 million in 2022, then surged by 179.09% to $123.4 million in 2023, then grew by 22.14% to $150.8 million in 2024, then fell by 6.33% to $141.2 million in 2025, then plummeted by 32.05% to $95.9 million in 2026.
  • The last three reported values for Invested Capital were $95.9 million (Q1 2026), $141.2 million (Q4 2025), and $150.8 million (Q4 2024) per Business Quant data.